Close Menu
    • ABOUT
    • BOOK STORE
    • ENTREPRENEURSHIP
    • ESG
    • EVENTS & AWARDS
    • POLITICS
    • GADGETS
    • CONTACT
    Facebook X (Twitter) Instagram
    Facebook X (Twitter) Instagram
    Business explainerBusiness explainer
    Subscribe
    • TRENDING
    • EXECUTIVES
    • COMPANIES
    • STARTUPS
    • GLOBAL
    • AGRICULTURE
    • DEALS
    • ECONOMY
    • MOTORING
    • TECHNOLOGY
    Business explainerBusiness explainer
    Home » SAHPRA Recalls Affected Batches Of Citro-Soda Regular Following Safety Concerns
    Health Science

    SAHPRA Recalls Affected Batches Of Citro-Soda Regular Following Safety Concerns

    March 26, 2026
    Facebook Twitter LinkedIn Telegram Pinterest Tumblr Reddit WhatsApp Email
    Dr. Boitumelo Semete – Makokotlela, CEO of SAHPRA, addressing the media in Pretoria.
    Share
    Facebook Twitter LinkedIn Pinterest Email

    The South African Health Products Regulatory Authority (SAHPRA) has briefed members of the media on the recall of specific batches of Citro-Soda Regular products, reaffirming its commitment to protecting public health and ensuring the safety, quality, and efficacy of all health products available in South Africa.

    The recall follows the identification of a potential risk of foreign material contamination during an inspection conducted at the Adcock Ingram Clayville, Johannesburg, manufacturing facility. As a precautionary measure, SAHPRA took regulatory action to recall the affected batches of these products.

    The recall is limited to specific batches  of the following Citro-Soda Regular products:

    • Citro-Soda Regular 60 g
    • Citro-Soda Regular 120 g
    • Citro-Soda Regular 4 g x 30 Sachets

    For affected batches of Citro-Soda Regular products, please click here.

    During the briefing, SAHPRA emphasised that this action forms part of its routine regulatory oversight and risk-based approach to safeguarding public health. SAHPRA also reassured the public that it continues to actively monitor the situation and engage with the manufacturer to ensure full compliance with regulatory requirements.

    Retail pharmacies, wholesalers, and distribution centres have been instructed to cease the sale of affected batches and to return all stock to their respective suppliers. Consumers who have purchased the affected products are advised to return them to the nearest health facility, pharmacy, or store.

    Members of the public who may have consumed the affected products and are experiencing any adverse side effects are urged to visit their nearest health facility and report such incidents to SAHPRA.

    “The safety and well-being of the public remain our highest priority. SAHPRA will continue to act decisively and transparently to ensure that all health products on the market meet the required standards, of quality, safety and efficacy,” said the Chief Executive Officer of SAHPRA, Dr Boitumelo Semete-Makokotlela.

    SAHPRA will continue to monitor this recall to ensure that all affected batches are destroyed. Furthermore, SAHPRA will monitor compliance at the affected facility until they have satisfactorily implemented corrective actions and preventative actions prescribed to them.

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Telegram Email
    Previous ArticleHigher Education, Google to Sign AI and Digital Skills Agreement
    Next Article ConCourt Shuts Door on Massmart’s R9m Strike Damages Claim

    Related Posts

    New Rules For Nigeria’s Beauty Industry

    March 16, 2026

    The Hidden Economics of Vaccine Supply

    March 11, 2026

    South Africa Accelerates Efforts to Eliminate HPV-Driven Cervical Cancer 

    December 10, 2025
    Top Posts

    Construction Boom Delivers 176,000 Jobs as Unemployment Eases

    November 11, 2025

    B-BBEE is Justice and the Only Way Forward, Says Dr Moleko

    November 16, 2025

    Volkswagen Chief Praises Chinese Competition for Sparking Innovation

    November 7, 2025

    Seven Families Sue OpenAI In ChatGPT Suicide Scandal

    November 10, 2025
    Don't Miss

    Black Doctors Disproportionately Audited but Not Racially Targeted, Report Finds

    FINANCE March 26, 2026

    South Africa’s medical schemes regulator has told parliament it will implement the recommendations of a…

    FirstRand Deepens Optasia Bet With R1.48bn Top-Up

    March 26, 2026

    ZIDO Brings Zimbabwe’s Property Market to Johannesburg

    March 26, 2026

    DBN Launches N$400m Financing Initiative for Women Entrepreneurs

    March 26, 2026
    Stay In Touch
    • Twitter
    • LinkedIn
    • Facebook
    About Us
    About Us

    From the latest product launches and company earnings to economic trends and industry disruptions, we distill the most critical details and implications – breaking through the jargon and wordiness to give you just what matters most.

    Facebook X (Twitter) LinkedIn
    Categories
    • TRENDING
    • EXECUTIVES
    • COMPANIES
    • STARTUPS
    • GLOBAL
    • AGRICULTURE
    • DEALS
    • ECONOMY
    • MOTORING
    • TECHNOLOGY
    contact us
    • Get In Touch
    © 2026 Business Explainer
    • Privacy Policy

    Type above and press Enter to search. Press Esc to cancel.